Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

InDex Pharmaceuticals will initiate patient recruitment for the Phase III study CONCLUDE after the summer

May 31, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that patient recruitment for the phase III study CONCLUDE is planned to initiate after the summer. The study will evaluate the efficacy and safety of the drug candidate cobitolimod for the treatment of moderate to severe left-sided ulcerative colitis.“The Covid-19 pandemic continues to affect significantly healthcare systems and regulatory authorities around the world, but the pressure is now decreasing in many countries. We therefore plan to initiate patient recruitment for the phase III study with cobitolimod on a

Eurocine Vaccines presentation från Aktieportföljen Live

Eurocine Vaccines presenterade verksamheten, framtidsplaner, vaccinmarknaden och samarbeten, bland annat relaterat till en vaccinkandidat mot klamydia, på Aktieportföljen Live den 26 maj 2021.Eurocine Vaccines VD Hans Arwidsson presenterade bolaget, bolagets framsteg i utvecklingen av vaccinkandidater och hur en vaccinportfölj byggs upp. Presentationen finns tillgänglig på Eurocine Vaccines på Aktieportföljen Live 

CELLINK completes the acquisition of Nanoscribe

As announced on May 19, 2021, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire the German company Nanoscribe Holding GmbH (“Nanoscribe”), an award-winning company focusing on development of high-precision 3D printers based on Two-Photon Polymerization technology (“2PP”). CELLINK has on this day completed the acquisition of all Nanoscribe-shares. The preliminary purchase price for all shares amounted to approximately €36.9 million, which is subject to adjustment for net cash/debt and deviation from normalized working capital according to the Closing Date Balance Sheet,

Asarina Pharma obtains convertible loan for continued research on neurological conditions including Obsessive Compulsive Disorder

(Stockholm, 31 May 2021) Asarina Pharma AB (publ) has obtained a convertible loan of 5.3 MSEK from Östersjöstiftelsen (ÖSS), one of its key shareholders, for ongoing and upcoming R&D into neurological disorders including OCD (Obsessive Compulsive Disorder).The convertible loan supplements Asarina Pharma’s current financial resources and will be spent on further exploration of the potential of Sepranolone within neurological diseases. The loan carries an interest rate of 10% p.a. and the maturity date is 30 June 2023. ÖSS has the right at any time before maturity to convert the loan to

Changes in the number of shares and votes in Betsson AB (publ)

As of 31 May 2021, the total number of shares in Betsson AB (publ) (the "Company") amounts to 281 145 568 shares, divided into: 31 822 000 class A shares; 243 246 060 class B shares and 6 077 508 class C shares. The total number of votes in the Company as of 31 May 2021 amounts to 567 543 568. At the Annual General Meeting held on 5 May 2021, one of the Company's resolved resolutions was to carry out an automatic share redemption scheme by adjusting the number of shares and votes in a share split (2:1). After this, Betsson’s redemption shares held by the Company itself have been

Scandinavian ChemoTech AB is gearing up after a successful CE marking

After Scandinavian ChemoTech secured the CE marking last week, of the IQwave™ and TSE platform, a number of projects and preparations are now being initiated. The purpose of these is to increase market activity in the countries and regions where the restrictions have eased up and now allow us to initiate started distribution agreements and get ready for the time that follows a global opening.The company's primary focus during the rest of the year will be to: · Carry out the registration processes of IQwave in countries where the Company already has distributor agreements and orders ·

TOMRA: Share purchase program for employees

As part of TOMRA's share purchase program for employees, approved by the Annual General Meeting on 4 May 2021, TOMRA has sold 11,744 shares (ticker TOM, ISIN NO0005668905) at a price equal to Monday 31 May's closing market share price, i.e. NOK 428.20.   After this transaction TOMRA holds 289,884 treasury shares. The share purchases on behalf of the following persons are considered as PDMR trades under the Market Abuse Regulation (EU) No 596/2014 ("MAR"), and as a result TOMRA Systems ASA is subject to information disclosure. Name Number of shares New shareholding

Xhail AB (publ) - Annual General Meeting of Shareholders

The shareholders of Xhail AB (publ), company registration number 556658-6797 (the “Company”), are hereby invited to participate in the Annual General Meeting (“AGM”) to be held June 28, 2021 at 10am  at the Company’s office at Eriksbergsgatan 10, 114 30 Stockholm, Sweden.Information about the coronavirus As a precautionary measure to reduce the risk of spreading the corona virus, the Board of Directors have decided that no food or beverages will be served. Only a few people from the Board of Directors and management will be present at the AGM, with the goal that the AGM will be short and

Bulletin from the Extraordinary General Meeting in EWPG Holding AB (publ)

The extraordinary general meeting in EWPG Holding AB (publ) was held on Monday 31 May 2021. The following resolutions, amongst others, were passed at the general meeting that was held by, and limited to, postal voting.Resolution on an authorization for the Board of Directors to increase the share capital The general meeting resolved, in accordance with the board of directors´ proposal to authorize the board of directors to to – during the period until the next annual general meeting and at one or more occasions – resolve upon issuance of new shares, warrants and/or convertible debentures,

Sinch AB (publ): Change in number of shares and votes in Sinch AB (publ)

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH The total number of shares and votes in Sinch AB (publ), reg. no. 556882-8908 (“Sinch”), has changed during the month of May consequent upon the directed issue of 7,232,077 new shares to certain Swedish and international institutional investors. Subsequent to the directed share issue, the total number of shares and votes in Sinch as of May 31, 2021, was 72,267,211. Through the directed share issue, Sinch’s share capital has increased with SEK 723,207.7, and, as of May 31, 2021, amounted to SEK 7,226,721.1. For further information,

Change in number of shares and votes in Samhällsbyggnadsbolaget i Norden AB

Pursuant to the Swedish Financial Instruments Trading Act, Swedish companies whose shares are listed on a regulated market and that increase or reduce the total number of shares or votes in the company must disclose such changes on the last trading day the same month. On 3 May 2021, SBB announced the outcome of the extended acceptance period in the mandatory offer to the shareholders in Offentliga Hus i Norden AB (publ) (“Offentliga Hus”) (the “Offer”). As consideration to the shareholders in Offentliga Hus electing share consideration during the extended acceptance period in the Offer,

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 31.05.2021

United Bankers Corporation NOTIFICATION 31.05.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 31.05.2021 Date 31.05.2021Exchange transaction BuyShare class UNITEDAmount 243Average price/share 13.4000 EURHighest price/share 13.4000 EURLowest price/share 13.4000 EURTotal price 3,256.20 EUR The shares held by United Bankers Corporation on 31.05.2021: UNITED 44,752   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Conversion of shares in Electrolux Professional

According to the articles of association of Electrolux Professional AB (publ), owners of Series A shares are entitled to request that such shares are converted to Series B shares.During May 2021, 847 Series A shares were converted to Series B shares at the request of the shareholders, following which the total number of voting rights in the company amounts to 35,984,533.5. The total number of registered shares in the company amount to 287,397,450 of which 8,049,765 are Series A and 279,347,685 are Series B. This information is information that Electrolux Professional AB (publ) is

Number of shares in G5 Entertainment AB (publ) on May 31, 2021

87,800 c-shares have been reclassified to ordinary shares during May to secure the delivery of shares within the frame of the performance based, long-term share program for the executive management and key employees (LTIP 2018/2021) that was accepted at the extraordinary general meeting on November 7, 2018. As a result, the structure of the shares and the number of votes in G5 Entertainment AB (publ) has changed.   As per todays date the total amount of shares in the company amounts to 9,105,180, split between 8,933,650 ordinary shares and 172,200 c-shares. Every ordinary share

The outbreak of mucormycosis (the so-called “Black Fungus”) in India is a prime example of the great need for a safer antifungal drug with true fungicidal activity

Monday, May 31, 2021: India is seeing an outbreak of an opportunistic fungal infection called mucormycosis. The outbreak, which is rapidly approaching epidemic proportions, is caused by the Mucormycetes fungus, otherwise known as the Black Fungus because it makes the infected tissue go black, and kills approximately half of those affected. The only effective treatment is a drug called Amphotericin B. Unfortunately the use of Amphotericin B in India is particularly challenging because of the drugs’ well known kidney toxicity. BGS005 is active against this fungus and would be a safe alternative

European Lingerie Group AB publishes unaudited First Quarter 2021 Report

European Lingerie Group AB (“ELG” or the “Group“) publishes unaudited First Quarter 2021 Report (1 January – 31 March 2021), including condensed interim consolidated financial statements.“The first quarter of 2021 continued to be a challenging quarter for the Company. Most of our main markets were still hit by COVID-19 lockdowns and traditional shopping was restricted throughout the whole Europe. We are pleased to acknowledge that the management of the Group companies is responding quickly to the new reality and keeps managing the situation accordingly. Irrespective of the COVID-19 imposed

One RescueRunner system ordered by the Swedish Sea Rescue Society (SSRS)

SSRS has ordered a RescueRunner system and is further expanding the RescueRunner fleet.SSRS already has an impressive 57 RescueRunners in their fleet and is the organization in the world that has the most RescueRunners in operation. Their RescueRunner systems are spread over 73 rescue stations around Sweden and they are now ordering a new RescueRunner for their important activities. The RescueRunner system is the fifth system that SSRS has ordered this year. "We are very pleased that SSRS now chooses to order yet another RescueRunner system and we hope that this boat also will be a

Record date for the share split in K-Fast Holding AB resolved to 8 June 2021

At the Annual General Meeting of K-Fast Holding AB (publ) on 19 May 2021, it was decided, in accordance with the Board’s proposal, to divide the shares so that each existing share is divided into six shares of the same share class, so-called share split 6:1. The Board was authorized to determine the record date (Sw. avstämningsdag) for the share split.The Board of Directors has resolved that the record date for the share split shall be Tuesday, 8 June 2021. This means that the last day for trading in the share before the split is Friday, 4 June 2021 and that the first day for trading in the

Endomines announces change of Interim CEO

Endomines AB, Stock Exchange Release 31 May 2021 at 16:45 CESTEndomines announces that Interim CEO Rauno Pitkänen has informed the Board of the Company that he will be retiring and resigning his position as of May 31, 2021. Deputy CEO Marcus Ahlström will take on the interim CEO position for now until the question of permanent CEO has been resolved. The Board estimates to be able to make an announcement of appointing a permanent CEO in the autumn 2021.  Chairman Ingmar Haga: “The Board wants to thank Rauno Pitkänen for his work as interim CEO during these challenging times for the

Change in number of shares and votes in AAK AB (publ.)

The long-term incentive program for employees (“Warrants Program series 2017/2022:2”) implemented at the annual general meeting on May 17, 2017 has resulted in the number of shares and votes in the company having increased during May 2021 by 70,500 shares and votes, through conversion of subscription warrants into new shares in the company. As of May 31, 2021, there are in total 256,495,938 shares and votes in the company.  For more information, please contact:Gabriella GrotteHead of Investor Relations and Corporate Communications Mobile: +46 737 16 80 01E-mail: gabriella.

#21-182 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

May 31, 2021 - On April 26, 2021, Asetek A/S launched a share buyback programme, as described in company announcement of April 26, 2021. According to the programme, Asetek A/S will in the period until September 2, 2021 buy back own shares up to a maximum value of USD 3 million and with a maximum of 237,100 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and Commission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

There are no items matching the current filter
There are no more items matching the current filter
Back to top